Inclusion Criteria:  Patients with systemic sclerosis according to 2013 ACR/EULAR criteria Patients with interstitial lung disease affecting at least 10 % of the lungs on HRCT chest, FVC of at least 40 % of the predicted value and DLCO between 30 % and 90 % of the predicted value Use of JAK inhibitors  Exclusion Criteria:  Patients with an alternative diagnosis of SSc-associated ILD (silicosis, sarcoidosis, lung cancer or other significant lung abnormalities) Patients with pulmonary arterial hypertension defined on right heart catheterization